Clinical Perspectives of Urocortin and Related Agents for the Treatment of Cardiovascular Disease

被引：4

作者：

Ikeda, Keiichi ^{[1
]}

Fujioka, Kouki ^{[1
]}

Manome, Yoshinobu ^{[1
]}

Tojo, Katsuyoshi ^{[2
]}

机构：

[1] Jikei Univ, Sch Med, Inst DNA Med, Dept Mol Cell Biol,Res Ctr Med Sci, Tokyo 1058461, Japan

[2] Jikei Univ, Sch Med, Dept Internal Med, Div Diabet & Endocrinol, Tokyo 1058461, Japan

来源：

INTERNATIONAL JOURNAL OF ENDOCRINOLOGY | 2012年 / 2012卷

关键词：

CORTICOTROPIN-RELEASING-FACTOR; ATRIAL-NATRIURETIC-PEPTIDE; ANGIOTENSIN-CONVERTING ENZYME; ISCHEMIA-REPERFUSION INJURY; MEAN ARTERIAL-PRESSURE; FACTOR CRF; RAT-HEART; PLASMA UROCORTIN; PROTEIN-KINASE; RECEPTOR;

D O I：

10.1155/2012/198628

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

The effects of corticotropin-releasing hormone, also known as corticotropin-releasing factor (CRF), on the cardiovascular system have been intensively researched since its discovery. Moreover, the actions of urocortin (Ucn) I on the cardiovascular system have also been intensively scrutinized following the cloning and identification of its receptor, CRF receptor type 2 (CRFR2), in peripheral tissues including the heart. Given the cardioprotective actions of CRFR2 ligands, the clinical potential of not only Ucn I but also Ucn II and III, which were later identified as more specific ligands for CRFR2, has received considerable attention from researchers. In addition, recent work has indicated that CRF type 1 receptor may be also involved in cardioprotection against ischemic/reperfusion injury. Here we provide a historical overview of research on Ucn I and related agents, their effects on the cardiovascular system, and the clinical potential of the use of such agents to treat cardiovascular diseases.

引用

页数：5

共 69 条

[1] The cardiovascular physiologic actions of urocortin II: Acute effects in murine heart failure [J].

Bale, TL ;

Hoshijima, M ;

Gu, Y ;

Dalton, N ;

Anderson, KR ;

Lee, KF ;

Rivier, J ;

Chien, KR ;

Vale, WW ;

Peterson, KL .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2004, 101 (10) :3697-3702

[2] Urocortin protects against ischemic and reperfusion injury via a MAPK-dependent pathway [J].

Brar, BK ;

Jonassen, AK ;

Stephanou, A ;

Santilli, G ;

Railson, J ;

Knight, RA ;

Yellon, DM ;

Latchman, DS .

JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (12) :8508-8514

[3] Urocortin-II and Urocortin-III are cardioprotective against ischemia reperfusion injury: An essential endogenous cardioprotective role for corticotropin releasing factor receptor type 2 in the murine heart [J].

Brar, BK ;

Jonassen, AK ;

Egorina, EM ;

Chen, A ;

Negro, A ;

Perrin, MH ;

Mjos, OD ;

Latchman, DS ;

Lee, KF ;

Vale, W .

ENDOCRINOLOGY, 2004, 145 (01) :24-35

[4] Specificity and regulation of extracellularly regulated kinase1/2 phosphorylation through corticotropin-releasing factor (CRF) receptors 1 and 2β by the CRF/urocortin family of peptides [J].

Brar, BK ;

Chen, A ;

Perrin, MH ;

Vale, W .

ENDOCRINOLOGY, 2004, 145 (04) :1718-1729

[5] Activation of protein kinase B/Akt by urocortin is essential for its ability to protect cardiac cells against hypoxia/reoxygenation-induced cell death [J].

Brar, BK ;

Stephanou, A ;

Knight, R ;

Latchman, DS .

JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY, 2002, 34 (04) :483-492

[6] Minireview: Natriuretic peptides during development of the fetal heart and circulation [J].

Cameron, VA ;

Ellmers, LJ .

ENDOCRINOLOGY, 2003, 144 (06) :2191-2194

[7] Protective effects of the urocortin homologues stresscopin (SCP) and stresscopin-related peptide (SRP) against hypoxia/reoxygenation injury in rat neonatal cardiomyocytes [J].

Chanalaris, A ;

Lawrence, KM ;

Stephanou, A ;

Knight, RD ;

Hsu, SY ;

Hsueh, AJW ;

Latchman, DS .

JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY, 2003, 35 (10) :1295-1305

[8] Plasma urocortin 1 in sheep: Regional sampling and effects of experimental heart failure [J].

Charles, Christopher J. ;

Rademaker, Miriam T. ;

Richards, A. Mark ;

Yandle, Timothy G. .

PEPTIDES, 2006, 27 (07) :1801-1805

[9] Urocortin 2 induces potent long-lasting inhibition of cardiac sympathetic drive despite baroreflex activation in conscious sheep [J].

Charles, Christopher J. ;

Jardine, David L. ;

Rademaker, Miriam T. ;

Richards, A. Mark .

JOURNAL OF ENDOCRINOLOGY, 2010, 204 (02) :181-189

[10] Abnormal adaptations to stress and impaired cardiovascular function in mice lacking corticotropin-releasing hormone receptor-2 [J].

Coste, SC ;

Kesterson, RA ;

Heldwein, KA ;

Stevens, SL ;

Heard, AD ;

Hollis, JH ;

Murray, SE ;

Hill, JK ;

Pantely, GA ;

Hohimer, AR ;

Hatton, DC ;

Phillips, TJ ;

Finn, DA ;

Low, MJ ;

Rittenberg, MB ;

Stenzel, P ;

Stenzel-Poore, MP .

NATURE GENETICS, 2000, 24 (04) :403-409

← 1 2 3 4 5 6 7 →